Ironvine Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.6M Sell
73,044
-3,933
-5% -$1.59M 3.07% 14
2025
Q1
$38.3M Buy
76,977
+4,188
+6% +$2.08M 4.16% 11
2024
Q4
$37.9M Sell
72,789
-4,916
-6% -$2.56M 4.06% 11
2024
Q3
$48.1M Buy
77,705
+205
+0.3% +$127K 5.16% 7
2024
Q2
$42.9M Sell
77,500
-29
-0% -$16K 4.69% 6
2024
Q1
$45.1M Buy
77,529
+285
+0.4% +$166K 4.94% 5
2023
Q4
$41M Sell
77,244
-3,156
-4% -$1.68M 4.92% 5
2023
Q3
$40.7M Buy
80,400
+830
+1% +$420K 5.22% 4
2023
Q2
$41.5M Sell
79,570
-726
-0.9% -$379K 5.04% 6
2023
Q1
$46.3M Buy
80,296
+225
+0.3% +$130K 5.84% 2
2022
Q4
$44.1M Buy
80,071
+4,019
+5% +$2.21M 5.71% 2
2022
Q3
$38.6M Buy
76,052
+3,088
+4% +$1.57M 5.18% 3
2022
Q2
$39.6M Buy
72,964
+1,124
+2% +$611K 4.87% 4
2022
Q1
$42.4M Buy
71,840
+1,661
+2% +$981K 4.58% 5
2021
Q4
$46.8M Sell
70,179
-10,096
-13% -$6.74M 4.8% 4
2021
Q3
$45.9M Buy
80,275
+2,574
+3% +$1.47M 4.87% 4
2021
Q2
$39.2M Buy
77,701
+23,255
+43% +$11.7M 4.29% 7
2021
Q1
$24.8M Buy
54,446
+792
+1% +$361K 2.89% 14
2020
Q4
$25M Sell
53,654
-7,160
-12% -$3.33M 3.12% 12
2020
Q3
$26.9M Buy
60,814
+18
+0% +$7.95K 3.36% 11
2020
Q2
$22M Buy
60,796
+44
+0.1% +$15.9K 2.91% 14
2020
Q1
$17.2M Buy
60,752
+8,871
+17% +$2.52M 2.69% 14
2019
Q4
$16.9M Buy
51,881
+859
+2% +$279K 2.35% 17
2019
Q3
$14.5M Buy
51,022
+4,950
+11% +$1.4M 2.12% 19
2019
Q2
$13.3M Buy
46,072
+2,854
+7% +$823K 2.17% 22
2019
Q1
$11.8M Buy
+43,218
New +$11.8M 2.23% 17